ST. LOUIS (KMOX) – A cheap chemotherapy drug tested in St. Louis has been found to extend life for more than a year for men whose prostate cancer has spread.
Men who received docetaxel lived nearly 58 months longer, versus 44 months for those who only received hormone therapy.
“Saint Louis University was one of the trial sites for this trial, and so we do intend to continue this treatment with patients who have metastatic disease,” says SLU Hospital urologist Dr. Sameer Saddiqui. “Instead of giving them hormones alone, we’re going to give them hormones and chemotherapy.”
Side effects include possible fever and a tingling in the fingers and toes, but Saddiqui says the extended survival rate is well worth that trade off.
(TM and © Copyright 2014 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2014 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)
MORE HEALTH NEWS:
- Metro East Hospital Holds Topping Off Ceremony
- Study Shows ‘Biggest Loser’ Candidates Regained Weight Over Time
- MDC Amps Up Measures to Prevent Spread of CWD
- Working Overnight, Rotating Shifts Increase Risk of Heart Disease
- Fighting to Lower Drug Overdose Deaths
- Local DEA Pushes Bill for Prescription Drug Monitoring Program